Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE002 (USA) (Dr. Nolan)
· consented 2023-08-02
Adverse events
4
Serious AEs
1
Open data queries
0
Luna dropout signal
–
Adverse events
severe
serious
assessed
2026-08-18
Grade 3 Hypothyroidism — outcome: RECOVERED/RESOLVED; onset 2023-11-21 (study day 106); relationship: not assessed; serious criteria: hospitalization
moderate
assessed
2026-08-18
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2024-01-28 (study day 174); relationship: N
mild
assessed
2026-08-18
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2024-03-31 (study day 237); relationship: N
severe
assessed
2026-08-18
Grade 3 Vomiting — outcome: RECOVERED/RESOLVED; onset 2024-06-04 (study day 302); relationship: N
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.